Cargando…

Impact of Bromocriptine-QR Therapy on Glycemic Control and Daily Insulin Requirement in Type 2 Diabetes Mellitus Subjects Whose Dysglycemia Is Poorly Controlled on High-Dose Insulin: A Pilot Study

Background. The concurrent use of a postprandial insulin sensitizing agent, such as bromocriptine-QR, a quick release formulation of bromocriptine, a dopamine D2 receptor agonist, may offer a strategy to improve glycemic control and limit/reduce insulin requirement in type 2 diabetes (T2DM) patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roe, Erin D., Chamarthi, Bindu, Raskin, Philip
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427808/ https://www.ncbi.nlm.nih.gov/pubmed/26060825 http://dx.doi.org/10.1155/2015/834903

Ejemplares similares

Timed Bromocriptine-QR Therapy Reduces Progression of Cardiovascular Disease and Dysglycemia in Subjects with Well-Controlled Type 2 Diabetes Mellitus
por: Chamarthi, Bindu, et al.
Publicado: (2015)

Bromocriptine and insulin sensitivity in lean and obese subjects
por: Bahler, L, et al.
Publicado: (2016)

Bromocriptine-QR Therapy Reduces Sympathetic Tone and Ameliorates a Pro-Oxidative/Pro-Inflammatory Phenotype in Peripheral Blood Mononuclear Cells and Plasma of Type 2 Diabetes Subjects
por: Cincotta, Anthony H., et al.
Publicado: (2022)

Effect of Bromocriptine-QR (a Quick-Release Formulation of Bromocriptine Mesylate) on Major Adverse Cardiovascular Events in Type 2 Diabetes Subjects
por: Gaziano, J. Michael, et al.
Publicado: (2012)

Effect of Bromocriptine‐QR (a Quick‐Release Formulation of Bromocriptine Mesylate) on Major Adverse Cardiovascular Events in Type 2 Diabetes Subjects
Publicado: (2015)

Evaluation of the efficacy and safety of bromocriptine QR in type 2 diabetes
por: Ramteke, Karuna Balwant, et al.
Publicado: (2011)

Bromocriptine mesylate: Food and Drug Administration approved new approach in therapy of non-insulin dependant diabetes mellitus with poor glycemic control
por: Keche, Yogendra
Publicado: (2010)

Effects of Bromocriptine on Glucose and Insulin Dynamics in Normal and Insulin Dysregulated Horses
por: Loos, Caroline M. M., et al.
Publicado: (2022)

Efficacy of bromocriptine on glycemic and metabolic control of prediabetic patients
por: Khalilzade, Saied Hossein, et al.
Publicado: (2015)

Insulin as a Tool in Factitious Dysglycemia
por: Odhaib, Samih A, et al.
Publicado: (2021)

Circadian‐timed quick‐release bromocriptine lowers elevated resting heart rate in patients with type 2 diabetes mellitus
por: Chamarthi, Bindu, et al.
Publicado: (2019)

Favorable Glycemic Control with Once-Daily Insulin Degludec/Insulin Aspart after Changing from Basal Insulin in Adults with Type 2 Diabetes
por: Jang, Han Na, et al.
Publicado: (2019)

Glycemic Control and Awareness of Insulin Therapy
por: Pashchenko, Yegor, et al.
Publicado: (2021)

Brain Dopamine–Clock Interactions Regulate Cardiometabolic Physiology: Mechanisms of the Observed Cardioprotective Effects of Circadian-Timed Bromocriptine-QR Therapy in Type 2 Diabetes Subjects
por: Cincotta, Anthony H.
Publicado: (2023)

Use of an Insulin Bolus Advisor Improves Glycemic Control in Multiple Daily Insulin Injection (MDI) Therapy Patients With Suboptimal Glycemic Control: First results from the ABACUS trial
por: Ziegler, Ralph, et al.
Publicado: (2013)

Autoantibodies to Insulin and Dysglycemia in People With and Without Diabetes: An Underdiagnosed Association
por: Pavithran, Praveen Valiyaparambil, et al.
Publicado: (2016)

Bilateral lower limb edema induced by rapid improvement of glycemic control with insulin therapy in a subject with poorly controlled type 2 diabetes
por: Kan, Yuki, et al.
Publicado: (2017)

Defining the Relative Role of Insulin Clearance in Early Dysglycemia in Relation to Insulin Sensitivity and Insulin Secretion: The Microbiome and Insulin Longitudinal Evaluation Study (MILES)
por: Wood, Alexis C., et al.
Publicado: (2021)

Insulin Resistance and the Risk of Diabetes and Dysglycemia in Korean General Adult Population
por: Baek, Jong Ha, et al.
Publicado: (2018)

Impact of Alcohol on Glycemic Control and Insulin Action
por: Steiner, Jennifer L., et al.
Publicado: (2015)

Glycemic Effects of Once-a-Day Rapid-Acting Insulin Analogue Addition on a Basal Insulin Analogue in Korean Subjects with Poorly Controlled Type 2 Diabetes Mellitus
por: Choe, Eun Yeong, et al.
Publicado: (2012)

Glargine insulin: an alternative to regular insulin for glycemic control in critically ill patients
por: Bhattacharyya, M, et al.
Publicado: (2007)

Effects of Twice-Daily Injections of Premixed Insulin Analog on Glycemic Control in Type 2 Diabetic Patients
por: Shimizu, Hiroaki, et al.
Publicado: (2010)

Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes
por: Via, Michael A, et al.
Publicado: (2010)

Once-Weekly Basal Insulin Fc Demonstrated Similar Glycemic Control to Once-Daily Insulin Degludec in Insulin-Naive Patients With Type 2 Diabetes: A Phase 2 Randomized Control Trial
por: Bue-Valleskey, Juliana M., et al.
Publicado: (2023)

Achieving glycemic control with intensive insulin therapy in the ICU
por: Vakalos, A, et al.
Publicado: (2008)

Effect of bromocriptine on glycemic control, risk of cardiovascular diseases and weight in patients with type 2 diabetes: a systematic review
por: Birhan, Mulualem Tesfaye, et al.
Publicado: (2023)

Association of Insulin Resistance and β-cell Function With Bone Turnover Biomarkers in Dysglycemia Patients
por: Guo, Hui, et al.
Publicado: (2021)

Changes in Glycemic Control and Quality of Life in Pediatric Type 1 Diabetics with Continuous Subcutaneous Insulin Infusion of Insulin Aspart Following Multiple Daily Injection Therapy
por: Kawamura, Tomoyuki, et al.
Publicado: (2008)

In Vivo Actions of Peroxisome Proliferator–Activated Receptors: Glycemic control, insulin sensitivity, and insulin secretion
por: Eldor, Roy, et al.
Publicado: (2013)

Protein Intake Among Patients with Insulin-Treated Diabetes is Linked to Poor Glycemic Control: Findings of NHANES Data
por: Bawadi, Hiba, et al.
Publicado: (2022)

Efficacy of insulin lispro in improving glycemic control in gestational diabetes
por: Deepaklal, M.C., et al.
Publicado: (2014)

Synthesis and Evaluation of the Insulin–Albumin Conjugate with Prolonged Glycemic Control
por: Rao, Shrilakshmi Sheshagiri, et al.
Publicado: (2022)

Bistable insulin response: The win-win solution for glycemic control
por: Akhtar, Javed, et al.
Publicado: (2022)

Metabolic Adaptation in Lactation: Insulin-dependent and -independent Glycemic Control
por: Fu, Ling, et al.
Publicado: (2022)

Biphasic insulin aspart‐30 reduces glycemic variability to a greater degree than insulin detemir: A randomized controlled trial of once‐daily insulin regimens using continuous glucose monitoring
por: Tsujino, Daisuke, et al.
Publicado: (2017)

Delay Of Insulin Addition To Oral Combination Therapy Despite Inadequate Glycemic Control: Delay of Insulin Therapy
por: Nichols, Gregory A., et al.
Publicado: (2007)

Triggering the adaptive immune system with commensal gut bacteria protects against insulin resistance and dysglycemia
por: Pomié, Céline, et al.
Publicado: (2016)

Comparison of a Multiple Daily Insulin Injection Regimen (Glargine or Detemir Once Daily Plus Prandial Insulin Aspart) and Continuous Subcutaneous Insulin Infusion (Aspart) in Short-Term Intensive Insulin Therapy for Poorly Controlled Type 2 Diabetes Patients
por: Lv, Wen-shan, et al.
Publicado: (2013)

Association of Dietary Glycemic Index, Glycemic Load, Insulin Index, and Insulin Load with Bacterial Vaginosis in Iranian Women: A Case-Control Study
por: Noormohammadi, Morvarid, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9far6lqjn3vjsfej2oe0e4ka9e